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Abstract
We propose a multiscale model of the invasion of the extracellular matrix by two types of can-
cer cells, the differentiated cancer cells and the cancer stem cells. We assume that the epithelial
mesenchymal-like transition between them is driven primarily by the epidermal growth factors. We
moreover take into account the transidifferentiation program of the cancer stem cells and the cancer
associated fibroblast cells as well as the fibroblast-driven remodelling of the extracellular matrix.
The proposed haptotaxis model combines the macroscopic phenomenon of the invasion of the
extracellular matrix with the microscopic dynamics of the epidermal growth factors. We analyse
our model in a component-wise manner and compare our findings with the literature. We in-
vestigate pathological situations regarding the epidermal growth factors and accordingly propose
“mathematical-treatment” scenarios to control the aggressiveness of the tumour.
1 Introduction
The mathematical study of cancer processes has been an active field of research since the 1950s; see, e.g.,
[40, 4, 14]. It covers a wide range of biological/bio-chemical processes of the tumour from the perspective
of modelling, analysis and numerical simulations, see, e.g., [44, 43, 3, 18, 15, 38, 49, 39, 24, 54, 19].
The nature of the cancer cells has also been under scientific scrutiny. In particular, although cancer
cells exhibit higher proliferation rates than normal cells, recent evidence has revealed the existence of
a subpopulation of the tumour that proliferates with lower rates, exhibits stem-like properties such as
self-renewal and cell differentiation, and is able to metastasize, i.e. to detach from the primary tumour,
invade the vascular system, and afflict secondary sites [6, 36]. These cancer cells, termed cancer stem cells
(CSCs), constitute only a minor part of the tumour, while its bulk is comprised by the more proliferative
and non-metastatic differentiated cancer cells (DCCs), [53, 46]. The CSCs were first demonstrated in
human acute myeloid leukemia and several solid tumours, such as breast, brain, melanoma, prostate,
ovarian, and pancreatic, see [13] and the references therein.
It is not completely known, where the CSCs originate from; a current theory states that they emanate
from the more usual DCCs after a de-differentiation program has taken place [19, 46]. This type of
transition of cancer cells, influences their cellular potency and seems to be related to the epithelial-
mesenchymal transition (EMT), a type of cellular de-differentiation program that can also be found in
normal tissue, [36]. After EMT the newly sprout CSCs take the first step in metastasis and invade the
Extracellular Matrix (ECM), what is considered the one of the “hallmarks of cancer”, cf. [53, 26].
The trigger of EMT is set by components of the micro-environment of the tumour [45]. A prime role in
this mechanism is played by the epidermal growth factor (EGF) that stimulates cell growth, proliferation,
and differentiation by binding to the corresponding cellular receptor EGFR [56, 48].
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Figure 1: Schematic representation of the CSCs’ participation in the metastasis of cancer. Showing here the
invasion, intravasation, and translocation of CSCs to the sites of metastasis. Showing moreover the EMT
transition from DCCs to CSCs (left part of the graph), and the transdifferentiation of CSCs to fibroblasts and
endothelial cells; Source [26]. ((Permission of the journal pending))
This process can be briefly described as follows: the binding of an EGF molecule onto an EGFR stimulates
ligand-induced dimerization that activates the protein-tyrosine kinase activity of the receptor which in
turn, initiates a signal cascade that results in a variety of changes within the cell and leading to DNA
synthesis. In certain pathological mutations they get stuck in the “on” position and cause unregulated
cell growth, untimely EMT, and over-expression of EGFRs. Over-expressed EGFRs are found in many
types of tumors, including breast, thyroid, ovarian, colon, head and neck, and brain. In addition, EGFR
over-expression has been linked to a poor prognosis in breast cancer and may promote proliferation,
migration, invasion, and cell survival as well as inhibition of cell apoptosis [16]. The role of EGFR as
oncogene [27] has led to the development of anticancer therapies targeted against the EGFR, the so-called
EGFR inhibitors, that promise improved treatment for many types of solid tumors.
In this work we consider a special type of taxis, namely the haptotaxis, in order to model the invasion of the
ECM by the DCCs and CSCs. Haptotaxis describes the biased random motion along directions of either
extracellular adhesion sites, or of the ECM-bound chemoattractants, or along their gradients. Haptotaxis
is typically modelled under the paradigm of the Keller-Segel (KS) systems1. Since their initial derivation,
KS systems have been successfully applied in a wide range of biological phenomena spanning from
bacterial aggregations to wound healing and cancer modeling. In cancer growth modelling in particular,
the Keller-Segel type systems were extended to include also enzymatic interactions/reactions, yielding
advection-reaction-diffusion (ARD) models, see for instance the generic haptotaxis system proposed in
[3] that takes into account ECM degradation by matrix metalloproteinases (MMPs), or the chemo-hapto-
taxis system proposed in [8] that addresses the role of the enzyme plasmin.
Besides degradation, the ECM is also dynamically remodelled; a process that is essential not only for
the developmental progress of healthy tissue (wound healing, organ homeostasis, etc.), but is also crucial
in the metastatic progression of cancer [9]. Specifically, the degradation of the “normal ECM” and its
replacement by “tumour induced ECM” leads to altered physiological conditions more advantageous for
the tumour, [25, 12]. Main characteristic in this process is the increased expression of fibroblast cells
which result from a transdifferentiation program of CSCs, see Figure 1 for a graphical depiction of the
aforementioned processes and refer to [26] for more details.
1First introduced in [28] to describe the aggregations of slime mold.
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Our main objective is to model the EMT transition of DCCs to CSCs, triggered by the interaction with
the EGF molecules found in the extracellular environment and the cellular EGF receptors (EGFRs). In
more detail, we couple the microscopic dynamics of the EGF attachment/detachment to EGFRs with
the macroscopic dynamics of the ECM invasion. We assume that these microscopic processes are much
faster than the kinematic properties of the cells, including their invasion of the ECM. The overall process
is limited by the availability of free EGF molecules and by the number of free EGFRs on the surfaces of
the cells.
The ECM invasion model that we have developed, is an ARD haptotaxis system that includes both
the DCCs and the CSCs, their kinematic properties, and the EMT. It moreover includes the ECM on
which the cancer cells adhere. We assume that the ECM is degraded by a class of matrix degenerating
metalloproteinases (MMPs) —secreted by the cancer cells. The ECM is also constantly remodelled
by fibroblast cells; which are assumed to emanate from the CSCs via a transdifferentiation program
[25, 12, 26].
We study the dynamics of the derived model on one- and two-dimensional computational domains. The
numerical treatment of such problems is challenging due to the inherent heterogeneous spatio-temporal
dynamics and the merging/emerging clusters of cancer cells that the solutions develop see, e.g., Figure
3. Thus, we employ a second order finite volume method equipped with a third order time integration
scheme, developed particularly for the needs of this type of problems, see Section 3 and our previous
works [34, 33] for more details. In our investigation we also include a sensitivity analysis of the model
with respect to its parameters. In particular, we investigate the effect that the parameters have on the
mass of the tumour and on the invasiveness of the DCCs and CSCs.
Similar ECM invasion systems that account for non-homogeneous cancer cell populations and the tran-
sition between them, exist in the literature see, e.g., [2, 10, 50]. However, in these works a detailed
investigation of the EMT triggering mechanism is not included, rather it is assumed that EMT takes
place with a constant ad hoc rate. With our model we can see the impact of pathological situations
(such as the EGF depletion), and to identify significant differences in the production of CSCs between
small and large tumours.
The rest of the paper is structured as follows: in Section 2 we derive our mathematical model. We
do so in a subsystem-by-subsystem way, and justify our choices in detail. In Section 3 we describe the
numerical method we use to resolve our model, and the method employed in the parameter sensitivity
analysis. In Section 4 we present and discuss a series of experiments aimed to highlight the influence
of the various model components, to compare with existing results from the literature, and to deduce
specific “mathematical-treatment” scenarios to control the aggressiveness of the CSCs.
2 Model
Our mathematical model is deterministic and phenomenological. The unknown variables represent den-
sities of the corresponding model components. More precisely, we include the two types of cancer cells
(DCCs and CSCs), the ECM, the fibroblast cells that are responsible for the remodelling of the matrix,
as well as matrix degenerating proteins. It consists of three subsystems a) the ECM invasion subsystem
in which the basic components of the haptotaxis movement of the cancer and fibroblast cells are included,
b) the EMT subsystem that is responsible for the EGF-driven transition of the CSCs to the DCCs, and
c) the ECM remodelling subsystem which addresses way the fibroblast cells reconstruct the ECM. In the
paragraphs that follow we present and justify each system separately, and at the end of this section we
concatenate them to derive the complete system.
2.1 The cancer invasion subsystem
This part of the model is based on the original derivation of a chemotaxis systems by Keller and Segel
(KS), [28]. Although these systems where initially developed to address the phenomenon of bacterial
aggregation, they have been very successful in applications to a wide range of biological phenomena, see,
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e.g., [35] and the references therein. In modelling cancer growth, KS-type systems have been adjusted
to address haptotaxis and a large variety of interactions between the cancer cells and the extracellular
environment, see, e.g., [1, 5, 3].
For our model we first employ the basic haptotactic system which features a) the cellular diffusion
and logistic proliferation of the cancer cells, b) the proteolysis of the ECM by matrix degenerating
metalloproteinases (MMPs), and c) the chemical degradation, diffusion of the MMPs as well as their
production by the cancer cells:

∂c
∂t
= Dc∆c− χ∇ · (c∇v) + µc(1− c− v)+
∂v
∂t
= −δmv
∂m
∂t
= Dm∆m+ αc− βm
, (1)
where the positive part function is defined as (x)+ = max {x, 0}. Here we denote the densities of the
cancer cells, ECM, and MMPs by c, v, and m respectively.
A first assumption we make in the model is that the cancer cells are “immortal”; we exclude hence any
terms that describe age-dependent cell death. In a similar way we exclude from the model cell death
due to overcrowding and the competition for free space, so in effect we consider the positive-part logistic
proliferation as opposed to the more usual logistic proliferation. Note moreover that the system (1), and
the ones that follow, are presented in their scaled non-dimensional version. We provide information on
the scaling coefficients and reference densities along with the parameter values in Table 1.
2.2 The EMT subsystem
Both species of cancer cells invade the ECM in a similar way. Indeed, we assume that they both satisfy
corresponding KS-type systems of the form (1). They are also coupled by the EMT, which works as a
loss/gain term between them:
∂cD
∂t
= diffusion + haptotaxis− µEMT cD + proliferation
∂cS
∂t
= diffusion + haptotaxis + µEMT c
D + proliferation
, (2)
where by cD, cS, and µEMT we denote the DCCs, CSCs, and EMT rate, respectively. As is typically done
in the modelling of reaction between two components, we assume that the EMT depends on the amount
of EGF —in particular on the occupied DCC-specific EGFRs— and on the local density of the DCCs.
We assume moreover that the µEMT is an increasing function of the occupied EGFRs that stagnates
asymptotically to a constant value i.e.:
µEMT = µ0
[g]DCCb
µ1/2 + [g]
DCC
b
, (3)
where [g]DCCb is the density of the EGF molecules that are bound onto the EGFRs, µ0 is the maximum
EMT rate, and µ1/2 a is the critical amount of bound EGF [g]
DCC
b needed to generate half of the
maximum EMT rate µ0. In effect, µ1/2 becomes the critical measure of EGF that characterizes the
non-uniform EMT.
This modelling approach is quite general as it includes both the EGF and the DCCs densities. It has
been motivated by similar previous approaches, i.e. [11, 57], and was also employed by us in [20].
Although a simplification of the biological reality, this choice of µEMT suffices to exhibit the importance
of considering non-uniform EGF-driven EMT rate, see also Section 4.
In the rest of this section we briefly describe the modelling/computation of µEMT, and refer to [20] for
more details. We set [g]f to represent the amount of EGF that is free in the extracellular environment,
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[g]0 the total (free and bound on both the DCCs and the CSCs) density of EGF. Accordingly, [r]0, [r]b,
and [r]f denote the total, occupied, and free receptors on the surface of cancer cells. We assume that
the EGF and EGFR are locally conserved:
[g]0(t, x) = [g]f (t, x) + [g]b(t, x) , (4)
[r]0(t, x) = [r]f (t, x) + [r]b(t, x) , (5)
for every t ≥ 0 and x ∈ Ω ⊂ R bounded. The binding/release of EGF to/from the EGFR receptors takes
place with rates k+/k− and is the same for both the DCCs and the CSCs, see also [57]. Moreover we
assume that the free EGF molecules diffuse in the extracellular environment:{
∂τ [g]b = k+[g]f [r]f − k−[g]b
∂τ [g]f = Df∆[g]f− k+[g]f [r]f + k−[g]b
, (6)
The dynamics in (6) take place during a microscopic time scale τ , which is related to the macroscopic
time t through:
τ(t) =
t
ε
, 0 < ε << 1 . (7)
We express by
(
gb(t, x), gf (t, x)
)
=
(
[g]b(τ(t), x), [g]f (τ(t), x)
)
the variables of the parabolic system
(6) in the t timescale and recall (5), to write the amount of free receptors as
[r]f = [r]0 − [r]b = λScS + λDcD − [g]b,
where λS, λD represent the total (free and bound) EGFR receptors per cell. We have assumed that each
EGFR receptor can be occupied by a single EGF molecule, i.e. [r]b = [g]b. We can now deduce from (6),
after taking the formal limit as ε→ 0 in (7), the elliptic system:
1
kD
gf
(
λScS + λDcD − gb
)− gb = 0
∆gf = 0
, (8)
where kD = k−/k+, the attachment/detachment ratio of the EGFs onto the EGFRs. The system (8) is
also augmented with homogeneous Neumann boundary conditions,
∂gf (x)
∂n
= 0, x ∈ ∂Ω . (9)
where n is the outward unit normal vector to the computational domain of the equation (8). The
uniqueness of the solution of (8)-(9) is recovered by the additional assumption that the total amount of
EGF remains constant,
Γ =
1
|Ω|
∫
Ω
g0(t, x) dx =
1
|Ω|
(∫
Ω
gb(t, x) dx+
∫
Ω
gf (t, x) dx
)
. (10)
With the above assumptions the system (8) can be solved to give
gb =
gf
kD + gf
(
λScS + λDcD
)
, (11)
and in particular
gDCCb =
gf
kD + gf
λDcD . (12)
When combined with (3) we obtain
µEMT = µ0
gfλ
DcD
µ1/2kD + µ1/2gf + gfλDcD
, (13)
which is non-uniform in space and time, see also Figure 2. On the other hand, the free EGF gf is
constant in space and is given by the unique positive root of the quadratic equation (see also [20] for
more details):
0 = g2f +
(
kD +
1
|Ω|
∫
Ω
λScS + λDcDdx− Γ
)
gf − Γ . (14)
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Figure 2: The coefficient µEMT depends non-uniformly on the space variable (here one-dimensional). This
follows from the dependence of µEMT on c
S (13) which makes it also time-dependent, for more details see [20].
2.3 Fibroblast cells and the matrix remodeling subsystem
We describe the remodelling of the ECM with two subsystems. In the first we introduce the transi-
tion/transdifferentiation of the CSCs to fibroblast cells, and in the second we model the reconstruction
of the ECM by the fibroblast cells. Contrary to the more usual assumptions of spontaneous or self-
remodeling of the ECM, we promote in this work the more biologically relevant fibroblast-driven matrix
remodelling.
The transdifferentiation subsystem. An potential initial distribution of fibroblast cells exists in the
environment and is locally enriched by a transdifferentiation programme of CSCs to cancer associated
fibroblast cells [26]. In this work we do not make a distinction between the two types of fibroblast cells, or
the two types of induced ECM, although they present different biochemical and mechanical properties.
We leave this question for a future investigation.
We assume that, similarly to the wound healing case, the fibroblast cells are directed towards regions
of the ECM that need reconstruction. We model this property with a haptotactic movement towards
lower densities of the ECM, [30]. This assumption is in a strong contrast to the haptotactic motion of
the DCCs and CSCs, which is oriented towards the higher ECM densities.
For their proliferation we employ the positive part logistic function to account only for the competition
for free space and neglect the overcrowding induced cell death. Since the fibroblast cells exhibit a much
shorter life span than the “immortal” cancer cells, we include an apoptosis term with constant rate. This
is a simplified assumption but suffices for the needs of this work. Accordingly, the transdifferentiation
subsystem reads as:
∂cS
∂t
= diffusion− χS∇ ·
(
cS∇v)− µTRA cCSC + proliferation
∂cF
∂t
= diffusion + χF∇ ·
(
cF∇v)+ µTRA cCSC + µF cF(1− cD − cS − cF − v)+ − βF cF , (15)
where cF represents the density of the fibroblast cells, χF their haptotactic sensitivity, µTRA their
transdifferentiation production coefficient, and µF and βF their proliferation and apoptosis/decay rate.
The matrix remodelling subsystem. Contrary to the more usual assumption of spontaneous or
self-remodelling of the ECM, we promote here the (more biologically relevant) fibroblast-driven ECM-
remodelling limited by the availability of the free space and encoded by a logistic term:
∂cF
∂t
= diffusion + haptotaxis + transdiff. + proliferation
∂v
∂t
= −proteolysis + µF cF(1− cD − cS − cF − v)+
, (16)
where we again consider the positive-part logistic volume filling reaction term to account only for the
remodelling of the matrix and not for its degradation. In fact, we assume that the matrix is degraded only
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by the proteolytic proteins MMP. The effect of the fibroblast-driven matrix remodelling in comparison
to the more usual self-remodelling can be seen in the Figure 5.
2.4 The full cancer invasion system
In total, the complete ECM invasion model results from the concatenation of the subsystems (1), (2),
(15), and (16) and reads as follows:
∂cD
∂t
= DD∆c
D − χD∇ ·
(
cD∇v) − µEMT cD + µD cD (1− cD − cS − cF − v)+ ,
∂cS
∂t
= DS∆c
S − χS∇ ·
(
cS∇v) −µTRA cS + µEMT cD + µS cS (1− cD − cS − cF − v)+ ,
∂cF
∂t
= DF∆c
F + χF∇ ·
(
cF∇v) +µTRA cS −βF cF + µF cF (1− cD − cS − cF − v)+ ,
∂v
∂t
= −δvmv + µv cF (1− cD − cS − cF − v)+ ,
∂m
∂t
= Dm∆m +αD c
D + αS
S, sim −βmm.
(17)
This system is complemented by appropriate initial conditions and no-flux boundary conditions:
−DD ∂c
D
∂n
+ χDc
D ∂v
∂n
= −DS ∂c
S
∂n
+ χSc
S ∂v
∂n
=
∂m
∂n
= 0 , (18)
where n is the outward unit normal vector to the computational domain Ω. The model parameters that
can be found in Table 1. They follow from investigations in the literature, e.g., [31, 2, 37], and from our
numerical experimentation, and reflect the current biological understanding of the problem.
3 Mathematical methods
In this section we present two mathematical techniques that we apply in order to investigate the dy-
namical behaviour of (17) and (18) and to predict the evolution of cancer cells. First we briefly describe
the main components of our higher order implicit-explicit finite volume numerical scheme. In the second
part we explain the way we compute parameter sensitivities.
3.1 Numerical method
It is well-known that the solutions of the macroscopic cancer invasion systems typically develop clusters of
cancer cell concentrations. The emerging of new clusters in time as well as their movement and interaction
with each other makes the numerical treatment particularly challenging. The partial differential equation
system (17) that we consider can be classified as an advection-diffusion-reaction system. A wealth of
numerical methods for these kind of systems in biological applications has been studied, for example, in
[21, 17, 34, 35].
For the numerical simulations in this work we apply the finite volume method which, we have developed
in [34, 33]. We first discretise in space to derive a system of ordinary differential equations
∂wh
∂t
= A(wh) +D(wh) +R(wh) , (19)
where wh denotes a vector carrying the values of a piecewise constant function on N spatially uniform
computational cells for all components of the system. The vector valued operators A, D, and R approxi-
mate the advection (i.e. haptotaxis), diffusion, and reaction terms of the system for every computational
cell and every component of a finite volume solution wh.
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We choose the diffusion and reaction operators in a conventional way. Central differences approximate
the second derivative in the diffusion operator D and reaction terms are directly evaluated at the cell
centers in the reaction operator R. In order to compute fluxes for haptotaxis in a given cell we employ
the dimensional splitting. Therefore we address briefly the advection operator A only in one-dimension.
Let ci be the density of a migrating cell type c (DCCs, CSCs, or fibroblasts) in the computational cell
Ci and ci+1, ci−1 the densities in the adjacent computational cells. We consider the approximation,∫
Ci
χ∇ · (c∇v) ≈ ai+1/2 ci+1/2 − ai−1/2 ci+1/2 , (20)
where ai±1/2 refers to the characteristic velocities, and ci±1/2 to the reconstruction of cell densities at
the interfaces of the computational cell.
The characteristic velocities in the haptotaxis case are proportional to the gradients of extracellular ma-
trix density v. These are approximated by two point central differences. For the interface reconstructions
we compute slopes, using the minimized-central (MC) limiter [55],
si = minmod
(
ci − ci−1, 1
4
(ci+1 − ci−1), ci+1 − ci
)
, (21)
where
minmod(a, b, c) =
{
min {|a|, |b|, |c|} sign(b), if a, b, c > 0, or a, b, c < 0 ,
0, otherwise .
Afterwards, we apply upwinding and define the reconstructed cell interfaces values
ci+1/2 = ci+1−1/2 =
{
ci + si, if ai+1/2 > 0 ,
ci+1 − si+1, otherwise .
(22)
The resulting system of ODEs (19) is stiff due to the approximate diffusion operator. To reduce the
number of time steps, which would be required by an explicit method, we employ implicit-explicit
(IMEX) Runge Kutta schemes [42, 29]. The time integration scheme reads as follows
Wi = w
n
h + ∆t
n
i−1∑
j=1
aEij (A+R)(Wj) + ∆tn
i∑
j=1
aIij D(Wj), i = 1, . . . , k + 1 , wn+1h = Wk+1 , (23)
thus we apply an explicit Runge Kutta method (aEij) to the advection and reaction terms coupled with
a diagonally implicit method (aIij) for the diffusion terms. The Butcher tableau we employ has been
derived in [29], and it yields a 4-stage scheme that is 3rd order accurate in time. The implicit treatment
of diffusion allows us to use time steps ∆tn proportional to the diameter of the computational cells, and
the Courant-Friedrichs-Lewy stability number 0.49. Note that in the case of the system (17) our method
is positivity preserving, i.e. given non-negative initial data, the numerical solution stays non-negative.
We have already successfully applied this numerical method to study a chemotaxis-haptotaxis cancer
system that promotes the role of urokinase in the invasion of the ECM, and a preliminary version of the
model (17), see [34, 20].
In Table 2 we demonstrate the second order experimental order of convergence (EOC) of our numerical
method in one- and two-space dimensions. To this end we have consecutively refined the grid globally
and compared the numerical solutions. The experimental order has been computed using EOC(N) =
log2(E(N) − E(N/2)), where E(N) is the numerical error on a grid with N mesh cells in each space
dimension. The convergence of the method justifies that the phenomena we exhibit in Section 4 are no
numerical artifacts but rather results of our mathematical model.
3.2 Parameter study
In phenomenological models like (17) the dependence of the system dynamics on changes of the parame-
ters is very interesting. Applying a local parameter analysis we can deduce the influence, that each part
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of the model has in the invasion process of the ECM by the cancer species. Accordingly, the parameters
can be adjusted to better fit the model to realistic experimental data.
For this process we recompute numerical solutions for the one-dimensional Experiment 1, see Section 4,
at the time instance t = 15, varying one parameter at time and measure real valued functionals F of the
solution with respect to the parameter changes. We are particularly interested in the mass of the DCCs
and CSCs over the whole domain Ω, the distance from the propagating CSC front to the slower DCC
front, which quantifies the invasiveness of the CSCs, and the concentration of mesenchymal cells in the
invading front.
For a more comprehensive overview of the influence of all model parameters, we have computed the
parameter sensitivity of the aforementioned functionals. This means that we compute approximate
derivatives of the functionals with respect to the parameters. Again, we consider here Experiment 1 at
t = 15. For feasibility we employ for each parameter p central differences around the corresponding value
p0 from Table 1 with a relative step size of δp = p0 × 10−2 to compute the sensitivities
SFp =
F(wht=15(p = p0 + δp))−F(wht=15(p = p0 − δp))
2δp
≈ ∂
∂p
F(wht=15) , (24)
where F is the functional of interest, and wht=15 is the numerical solution (all components) of system
(17), at time instance t = 15.
In Table 3 we present the results of this computation. Positive sensitivities SFp indicate an increase of
the functional F (in the corresponding column) when increasing the parameter p (in the corresponding
line), while negative sensitivities indicate a decrease of the functional when increasing p. The absolute
value quantifies the parameter influence on the corresponding attributes. Note that the sensitivity shows
the effect, when increasing the parameter by one unit. Zero sensitivities in the column for the front
distance mean that no influence on the relative invasion speed could be measured in the simulation. For
a discussion of the results of the parameter study we refer to the following section.
4 Experiments and discussion
The initial conditions that we use in the one-dimensional case are:
cD0 (x) = exp(−20x2) , cS0(x) = cF0 (x) = 0 , v0(x) = 1− 0.5 cD0 (x) , m0(x) = 0.2 cD0 (x) , (25)
for all x ∈ Ω, whereas in the two-dimensional case:
cD0 (x) =

sin
(
5 arctan
(
x2
x1
))
, if x21 + x
2
2 < 4, x2 ≤ 0, x1 ≥ 0 ,
sin
(
5
(
pi + arctan
(
x2
x1
)))
, if x21 + x
2
2 < 4, x2 ≤ 0, x1 < 0 ,
0, otherwise ,
(26)
cS0(x) = c
F
0 (x) = 0, v0(x) = 1− cD0 (x), m0(x) =
1
20
cD0 (x), x = (x1, x2) ∈ Ω . (27)
We use a fine computational grid with 7000 cells in the one-dimensional cases and 250× 250 for the two-
dimensional simulations. Further details on the various experimental settings are given in the Appendix.
Figure 3 presents the numerical solution of the system (17) over a one-dimensional domain with ICs (25)
and parameters taken from the Table 1. In the initial conditions no CSCs are included, rather they are
formed by the DCCs after undergoing EMT. The CSCs exhibit higher motility and invasiveness than the
DCCs, they escape the main body of the tumor and invade the ECM while developing highly dynamic
phenomena like the merging and emerging of concentrations. In a similar way, Figure 4 presents the
dynamics of the same model (17) and parameters on a two-dimensional domain. We see in particular,
laterally propagating waves in the migration of the CSCs, which are due to the non-convexity of the
DCC front in the initial conditions.
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parameter bio. relevant value rescaled value reference
DD diffusion coeff. of DCCs 3.5× 10−10 cm2s−1 3.5× 10−4 [7, 3, 8]
DS diffusion coeff. of CSCs 3.8× 10−11 cm2s−1 3.8× 10−5 [7, 2], our choice
DF diffusion coeff. of fibroblasts 3.5× 10−10 cm2s−1 3.5× 10−4 [31], our choice
Dm diffusion coeff. of MMPs 2.5× 10−9 cm2s−1 2.5× 10−3 [47, 52, 8]
χD haptotaxis coeff. of DCCs 1.3 cm
d+2mol−1s−1 8× 10−3 [52, 8]
χS haptotaxis coeff. of CSCs 62.5 cm
d+2mol−1s−1 4× 10−1 [52, 2], our choice
χf haptotaxis coeff. of fibroblasts 1.3 cm
d+2mol−1s−1 8× 10−3 [52], our choice
λD EGF receptors per DCC 1.9× 107 1 [22, 41, 32], our choice
λS EGF receptors per CSC 2.7× 107 1.4 [22, 41, 32], our choice
kD EGF unbinding/binding 3.2× 10−12 cm−dmol 2 [41], estimated
Γ average of total EGF 8× 10−14 cm−dmol 0.05 estimated
µ0 EMT factor 5.5× 10−6 s−1 0.055 estimated
µ1/2 critical EGF density 3.2× 10−12 cm−dmol 2 estimated
µD proliferation rate of DCCs 2× 10−5 s−1 0.2 [51, 8]
µS proliferation rate of CSCs 10
−5 s−1 0.1 our choice
µF proliferation rate of fibroblasts 10
−5 s−1 0.1 our choice
µv ECM remodelling rate 1.9× 108 s−1 25 our choice
βF apoptosis rate of fibroblasts 3× 10−7 s−1 3× 10−3 [31]
βm decay rate of MMPs 10
−4 s−1 1 [3]
αD MMP production rate of DCCs 2.3 s
−1 0.1 [3, 8]
αS MMP production rate of CSCs 22.9 s
−1 1 our choice
δv ECM degradation rate 5.3× 109 cmdmol−1s−1 1 [3, 8]
µTRA transdifferentiation rate 10
−6 s−1 0.01 estimated
cref reference cell density 8.3× 10−20 cm−dmol - [31]
vref reference ECM density 6.4× 10−9 cm−dmol - [31]
mref reference MMP density 1.9× 10−14 cm−dmol - [31]
gref reference EGF density 1.6× 10−12 cm−dmol - [23, 31]
D diffusion scaling coeff. 10−6 cm2s−1 - [7, 8]
tsc time scaling coeff. 10
4 s - [3, 8]
Table 1: Parameter values in their derived biological units and in a rescaled formulation which we have used
in our simulations. For the non-dimensionalization, the reference densities and the scaling coefficients in the
lower part of the table have been used. The integer d ∈ {1, 2} denotes the space dimension. Parameter values
referenced by “our choice” have been chosen according to our biological understanding of the processes, while
we have decided on “estimated” parameter values after numerical experimentation.
Grid L1 error EOC L2 error EOC
512/1024 1.953e-05 3.199e-05
1024/2048 4.430e-06 2.140 7.359e-06 2.120
2048/4096 1.061e-06 2.062 1.656e-06 2.152
4096/8192 2.569e-07 2.046 3.857e-07 2.102
Grid L1 error EOC L2 error EOC
16×16/32×32 1.020e-01 3.025e-02
32×32/64×64 3.090e-02 1.723 1.023e-02 1.564
64×64/128×128 8.453e-03 1.870 2.715e-03 1.914
128×128/256×256 2.180e-03 1.955 6.945e-04 1.967
Table 2: Experimental convergence rates of the numerical method presented in Section 3.1 employed in the
system (17) for the DCCs in one-dimensional (left) and two-dimensional (right). In the one-dimensional
case, Experiment 1 is performed for the final time t = 15, and in the two-dimensional case, Experiment 10
is realized for the final time t = 10. In both cases the results confirm the second order convergence of the
numerical method.
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Figure 3: Time evolution of the one-dimensional cancer invasion system (17). (a) the CSCs are produced
from the DCCs via the EMT, (b)-(c) due to their higher motility, the CSCs escape the main body of the tumor
and invade the ECM faster than the DCCs. Two distinct propagating fronts have been formed, (d)-(f) the
CSCs present dynamic travelling merging and emerging concentrations; the DCCs propagate into the ECM
slower. The computational setting is described in Experiment 1 in the Appendix.
In Figure 5 we compare three different types of ECM remodelling: the case without matrix remodelling
(Experiment IIa) is used for comparison reasons. The matrix is depleted by the MMPs, which is produced
by the cancer cells, creating “holes”in which the cells cannot attach and translocate. The case of
self remodelling is included as it is one of the most prominent in the literature. We see the stronger
confinement of both types of cancer cells and the “sharper” ECM. In the cancer-associated fibroblast
remodelling case we notice the faster invasion of the CSCs, as well as repair of the ECM by the fibroblast
cells.
In Figure 6 we compare different EMT strategies: we compare a typical constant EMT rate µEMT in
(17) and our EGF-driven µEMT coefficient proposed in (13). For the one-dimensional case we start this
comparison with parameters from Table 1 (modified to fit the one-dimensional case), and subsequently
adjusted it so that the invasiveness (propagating front of the CSCs and DCCs) and distributions of
the cancer cells coincide at different time instances for the constant rate and the EGF-driven EMT, see
Figure 6 upper and middle rows. In the lower row we consider the EGF-driven EMT and the pathological
situation, where the total amount of EGF given by Γ in (10) is extremely low (of the order of 10−3).
As expected only a small amount of DCCs have undergone EMT, leading to a small but still existent
number of CSCs which invade the ECM.
In Figure 7 we go one step further and first consider the same coefficients as the ones that give the
coincidence between the constant rate and the EGF-driven EMT, see Figure 6. We consider a small
initial tumour (with a maximum density of 10−3) and simulate the evolution of the cancer dynamics. We
see that in the constant rate EMT case, the CSCs quickly rise and achieve densities comparable to the
DCCs’. This means that the metastatic part of the tumour would be as detectable as its main body. In
contrast, in the EGF-driven EMT case, we observe that the density of the CSCs remains low (negligible
relatively to the DCCs for a long time), but start to increase later. But even in the initial phase a few
CSCS are present (relative number at t= 400 or so), and thus can invade the ECM. Our model hence is
able to produce a scenario where metastatic CSCs can be produced also by “small” tumours and remain
un-detectable in comparison to the main body of the DCCs.
11
parameter DCC mass CSC mass front distance front height
DD diffusion coeff. of DCCs +1.2342e+01 -8.1722e+00 +1.3714e+02 -7.3024e+01
DS diffusion coeff. of CSCs +9.4182e-02 -3.2915e-01 ±0 -9.5376e+03
DF diffusion coeff. of fibroblasts -2.2642e-02 +2.1300e-03 ±0 +3.9125e-01
Dm diffusion coeff. of MMPs -2.9334e-01 -9.5195e-02 -2.8800e+01 -1.6365e+02
χD haptotaxis coeff. of DCCs +8.9096e-01 -3.4507e-01 -1.3500e+01 -3.1985e+00
χS haptotaxis coeff. of CSCs -9.4425e-03 -3.5106e-03 +1.5600e+00 +4.9956e-01
χF haptotaxis coeff. of fibroblasts -7.0482e-03 -8.6437e-04 ±0 -1.6845e-03
λD EGF receptors per DCC -3.2691e-02 +4.6710e-02 +5.4000e-01 +7.5617e-01
λS EGF receptors per CSC +5.1239e-04 -6.5509e-04 ±0 -1.4768e-02
kD EGF unbinding/binding +5.1703e-02 -7.4019e-02 -8.6400e-01 -1.1744e+00
Γ average of total EGF -2.1830e-01 +3.1164e-01 +3.6000e+00 +5.0090e+00
µ0 EMT factor -6.6859e-02 +9.5767e-02 +1.1345e+00 +1.5432e+00
µ1/2 critical EGF density +1.7618e-02 -2.5178e-02 -2.8800e-01 -4.0878e-01
µD proliferation rate of DCCs +2.3304e-01 +3.9116e-02 +1.2000e-01 -6.8597e-04
µS proliferation rate of CSCs +2.2971e-04 +4.9220e-02 ±0 +4.6599e-03
µF proliferation rate of fibroblasts -1.3865e-04 -5.2592e-05 ±0 +1.1644e-03
µv ECM remodelling rate +5.2516e-02 +1.0917e-02 +6.6000e-01 +2.4808e-01
βF apoptosis of fibroblasts +1.2117e-03 +4.8903e-04 ±0 -7.7809e-03
βm decay rate of MMPs -4.7396e-02 -9.1276e-03 -4.9200e-01 -8.6865e-01
αD MMP production rate of DCCs +3.6965e-01 +2.6936e-02 ±0 +7.9042e-01
αS MMP production rate of CSCs +6.4883e-03 +6.6901e-03 +6.6000e-01 +1.3518e-01
δv ECM degradation rate -6.8955e-06 -4.4457e-06 ±0 -4.8110e-05
µTRA transdifferentiation rate -2.0113e-01 -6.7081e-01 -1.2000e+01 -3.6641e+01
Table 3: Sensitivity of model properties with respect to the model parameters in Experiment 1. A large absolute
value in the table indicates a high influence of the parameter (rows) on the corresponding attribute (column).
For details on the computation see Section 3.2, the results are discussed in Section 4.
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Figure 4: Time evolution of the two-dimensional cancer invasion system (17), in Experiment 7. Similar to
the one-dimensional case (Figure 3), the invasion of the DCCs onto the ECM is smooth and mostly driven by
proliferation and diffusion. The CSCs exhibit richer dynamics and patterns in their invasion. In particular,
laterally propagating and interacting waves appear due to the non-convexity of the front of the initial concen-
trations. The ECM is depleted by the MMPs which in turn are produced by the cancer cells and is constantly
remodelled by the fibroblast cells. An initially uniform distribution of the ECM is assumed.
Regarding the sensitivity of the model simulation from Table 3, cf. Section 3.2, we can see that the
invasiveness of the CSCs relative to the DCCs (quantified by the front peak distance) is not only affected
by the haptotactic sensitivity of both types of cancer cells, but also by the EGF. Indeed an increase
in the total amount of EGF, or in the EMT strength has a significant positive impact, while a higher
rate of fibroblast transdifferention would weaken the aggressiveness. Further, higher ECM remodelling
rates increase the tumor by increasing the mass of both cancer types, the invasiveness of the CS, and
also in the density of the invading CSCs (i.e. the CSC front height), see Figure 5 (compare bottom and
top row). The apoptosis of fibroblasts moreover supports the tumour while having a stronger influence
on the DCCs then on the CSCs. In comparison to the transdifferentiation, which weakens the tumour
growth overall, the proliferation of the fibroblasts has only a weak negative impact on the tumour size.
An increase in the number of EGF receptors on the DCCs would promote the EMT transition and thus
the mass, and the invasiveness of the DCCs. On the other hand, increasing the receptors on the CSCs
has the inverse but significantly weaker effect.
In Figure 8 we can see the effect that the EMT controlling parameters µ0, Γ, µ1/2 have on the mass and
on the primary propagating front of the DCCs and the CSCs. In particular we observe that the increase
of µ0 (maximum EMT rate) causes the depletion of the DCCs. Moreover, an increase of Γ (average EGF
in the environment) increases the amount of CSCs relative to DCCs, until an eventual stagnation of the
CSCs aggressiveness, with no change upon further increase in Γ. Higher values of the constant µ1/2 have
a somewhat different effect: the aggressiveness of CSCs (in both density and speed) decays as is their
total mass. Hence, increasing µ1/2, or decreasing µ0 and Γ would have a beneficial impact to the patient.
With our parameter investigations we have identified potential treatments that affect the invasiveness
13
DCC CSC ECM
n
o
re
m
o
d
el
li
n
g
0.3
0.6
0.9
0.017
0.033
0.05
0.3
0.7
1
se
lf
re
m
o
d
el
li
n
g
0.3
0.6
0.9
0.027
0.053
0.08
0.3
0.7
1
fi
b
ro
b
la
st
re
m
o
d
el
li
n
g
0.3
0.6
0.9
0.017
0.033
0.05
0.3
0.7
1
Figure 5: Comparison between three different types of ECM remodelling at time t = 90. (Upper row, Ex-
periment 8) The ECM is depleted by the MMPs and is not remodelled. Newly sprout CSCs in the kernel of
the tumour are unable to adhere and escape the main body of the tumour. This case is used for comparison
reasons. (Middle row, Experiment 9) The ECM is automatically recovered as long as there is some pre-existing
ECM. A non-uniform ECM is remodelled by filling the free volume leading to a uniform ECM distribution.
(Lower row, Experiment 7) The matrix is remodelled by fibroblast cells that are haptotactically directed towards
lower densities of the ECM. This recovers the matrix in the kernel of the tumour allowing for the CSCs to
adhere and escape the tumour.
and migration of the CSCs. Our model faithfully predicts, that decreasing the total amount of EGF in
the environment, or the maximum EMT rate µ0, or the amount of EGFRs λ
D, or increasing of µ1/2,
leads to a direct decrease of the EMT rate µEMT as one would expect based on the setting for the model.
Furthermore, the dependence of the mass of CSCs and DDCs on the effective EMT-rate agrees with the
expectations. But not only the height of the CSC front-peak, but also the difference between the position
of the peaks of the two cell populations is positively correlated with the effective EMT-rate and thus
with the CSC-mass. Similar results can be obtained by the inhibition of the remodelling of the ECM, or
by the enhancement of transdifferentiation, and by the prevention of fibroblast apoptosis.
In Figure 9 we can see the effect that an initially non-uniform ECM has on the migration of the cancer.
We note in particular, that the invasion is no longer uniform and it is highly influenced by the gradients
of the ECM. These can lead to the creation of islands/clusters of CSCs.
In Figure 10 we present the invasion of the ECM by the cancer cells using the full system (17) and
parameters from Table 1. We note that in the invasion of the CSCs nonlinear waves appear, that are
created by the interaction of their propagating fronts.
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Figure 6: Comparison between the constant rate EMT (upper row, Experiment 5), versus the EGF-driven
EMT, i.e. µEMT given by (13) (middle and lower rows, Experiments 2, 3). The parameters in the upper and
middle graph are based on the Table 1 and are adjusted so that the invasiveness of the CSCs and the DCCs
coincide. We observe that the components of the solution are qualitatively the same; there is a difference in the
number of peaks that the CSCs exhibit. In the third row, we present a particular experiment of the EGF-driven
EMT case, where the total EGF has been depleted to a low value (10−3). A single propagating low-density
peak of CSCs appears, demonstrating the adjustability of our model to the pathological situation of very low
EGF density.
5 Conclusion
The main goal of this work is to develop a mathematical model and get a deeper insight into the role of
EMT in the invasion of cancer. In particular, we integrate the EGF-driven-EMT theory and develop an
algebraic-elliptic model (8) to account for the amount of EGF molecules in the vicinity of a tumor. To
this end we introduce a non-constant EMT coefficient (13) that drives the de-differentiation of DCCs to
CSCs.
This EMT model is combined with a haptotaxis system of the Keller-Segel type modelling the invasion
of the ECM by both DCCs and CSCs. We endow the resulting system with a term describing the
degradation of the ECM by matrix degenerating MMPs secreted by both families of cancer cells, and by
the ECM remodelling driven by cancer associated fibroblast cells (16). The fibroblast cells are assumed
to be produced by the CSCs via a cell transdifferentiation program (15). Another particular component
of the proposed model is the positive-part logistic proliferation term. Numerically, we resolve the full
system in one- and two- spatial dimensions with a robust higher order implicit explicit finite volume
scheme developed in our previous works [34, 20].
With our numerical experiments, we are able to reproduce qualitatively the dynamic behaviour of the
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Figure 7: A comparison of the EGF-driven EMT (left, Experiment 4) with the constant rate EMT (right,
Experiment 6) in terms of the production of CSCs. We use the same parameters as in Figure 6 with an
initial DCC concentration of a maximum value 10−3. We can see that in the EGF-driven EMT case there is
no concentration of the CSCs comparable to the one of the DCCs until the DCC concentration has increased
considerably. Loosely translated, our model predicts that small tumours produce CSCs that cannot be detected
due to their low densities. On the other hand, in the constant rate EMT case the density of the CSCs raises
quickly to become comparable to the DCCs level and can be easily detected.
DCCs and the CSCs: the CSCs separate from the main body of the tumour, invade the ECM and
develop highly dynamic behaviour in the form of merging and emerging concentrations. We also show
that during the invasion of the ECM, the CSCs exhibit complex non-linear behaviour in the form of
propagating and interacting waves in both cases of initial uniform and non-uniform ECM.
We are moreover able to deduce information regarding the invasiveness of CSCs. Using the components
of the EMT subsystem we can suggest potential scenarios for their control. In particular, performing a
sensitivity analysis on the parameters of the models to verify that the parameters and components of
the EMT are among the most influential in the invasiveness and aggressiveness of the tumour. With our
study, we can see that the CSCs produced by small tumours become detectable only in later stages of
the evolution of the cancer; while in the meantime they migrate in a fast pace.
References
[1] W. Alt and D.A. Lauffenburger. Transient be-
havior of a chemotaxis system modelling cer-
tain types of tissue inflammation. J. Math.
Bio., 24(6):691–722, 1987.
[2] V. Andasari, A. Gerisch, G. Lolas, A.P. South,
and M.A.J. Chaplain. Mathematical modelling
of cancer cell invasion of tissue: biological in-
sight from mathematical analysis and compu-
tational simulation. J. Math. Biol., 63(1):141–
171, 2011.
[3] A.R.A. Anderson, M.A.J. Chaplain, E.L. New-
man, R.J.C. Steele, and A.M. Thompson.
Mathematical modelling of tumour invasion
and metastasis. Comput. Math. Method. M.,
2(2):129–154, 2000.
[4] P. Armitage and R. Doll. The age distribution
of cancer and a multi-stage theory of carcino-
genesis. Br. J. Cancer, 8(1):1, 1954.
[5] N. Bellomo, N.K. Li, and P.K. Maini. On
the foundations of cancer modelling: Selected
topics, speculations, and perspectives. Math.
Mod. Meth. Appl. S., 18(04):593–646, 2008.
[6] T. Brabletz, A. Jung, S. Spaderna, F. Hlubek,
and T. Kirchner. Opinion: migrating cancer
stem cells - an integrated concept of malig-
nant tumour progression. Nat. Rev. Cancer,
5(9):744–749, 2005.
[7] D. Bray. Cell movements: from molecules to
motility. Garland Science, 2001.
[8] M.A.J. Chaplain and G. Lolas. Mathemat-
ical modelling of cancer cell invasion of tis-
sue. the role of the urokinase plasminogen ac-
tivation system. Math. Mod. Meth. Appl. S.,
15(11):1685–1734, 2005.
[9] T.R. Cox and J.T. Erler. Remodeling and
homeostasis of the extracellular matrix: im-
plications for fibrotic diseases and cancer. Dis.
Model. Mech., 4(2):165–178, 2011.
[10] P. Domschke, D. Trucu, A. Gerisch, and
M.A.J. Chaplain. Mathematical modelling of
cancer invasion: Implications of cell adhesion
variability for tumour infiltrative growth pat-
terns. J. Theor. Biology, 361:41–60, 2014.
16
µ0
10 -4 10 -2 10 0 10 2
0
0.1
0.2
µ0
10 -4 10 -2 10 0 10 2
0
2
4
6
Γ
10 -4 10 -2 10 0
0
0.1
0.2
Γ
10 -4 10 -2 10 0
0
1
2
µ1/2
1 2 3 4 5
0
0.1
0.2
µ1/2
1 2 3 4 5
0
1
2
DCC mass CSC mass front peak distance CSC front height
Figure 8: The influence of the parameters µ0, Γ, µ1/2 on the mass and the invasiveness of the cancer cells.
(Upper row) High values of the maximum EMT rate µ0 in (3) promote the CSCs and deplete the DCCs (left).
The front distance between the two families of cancer cells and the density of the CSCs at the propagating
front increases (right). (Middle row) When the (average) mass of EGF Γ, cf. (10), increases, the masses of
the two cancer cell types are driven to a stable situation (left). Similarly, their relative invasiveness and the
density of the CSCs indicates stagnation (right). (Lower row) The increase of µ1/2 in (3) is beneficial for the
DCCs. It depletes the CSCs and decreases the density and the distance of the propagating fronts; in effect it
weakens the migration and growth of CSCs. This graph suggests that enhancing µ1/2 prevents the migration
of the CSCs, cf. Experiment 1.
[11] A. Eladdadi and D. Isaacson. A mathemati-
cal model for the effects of HER2 overexpres-
sion on cell proliferation in breast cancer. Bull.
Math. Biol., 70:1707–1729, 2008.
[12] J.T. Erler and V.W. Weaver. Three-
dimensional context regulation of metastasis.
Clin. Exp. Metastasis, 26(1):35–49, 2009.
[13] Y.L. Fan, M. Zheng, Y.L. Tang, and X.H.
Liang. A new perspective of vasculogenic
mimicry: EMT and cancer stem cells (review).
Oncol. Lett., 6(5):1174–1180, 2013.
[14] J.C. Fisher. Multiple-mutation theory of car-
cinogenesis. Nature, 181(4609):651–652, 1958.
[15] R. Ganguly and I.K. Puri. Mathematical
model for the cancer stem cell hypothesis. Cell
Proliferat., 39(1):3–14, 2006.
[16] D. Gao, L.T. Vahdat, S. Wong, J.C. Chang,
and V. Mittal. Microenvironmental regulation
of epithelial-mesenchymal transitions in can-
cer. Cancer Res., 72(19):4883–4889, 2012.
[17] A. Gerisch and M.A.J. Chaplain. Robust nu-
merical methods for taxis–diffusion–reaction
systems: Applications to biomedical problems.
Math. Comput. Model., 43(1):49–75, 2006.
[18] A. Gerisch and M.A.J. Chaplain. Mathemati-
cal modelling of cancer cell invasion of tissue:
Local and nonlocal models and the effect of ad-
hesion. J. Theor. Biol., 250(4):684–704, 2008.
[19] P.B. Gupta, C.L. Chaffer, and R.A. Weinberg.
Cancer stem cells: mirage or reality? Nat.
Med., 15(9):1010–1012, 2009.
[20] N. Hellmann, N. Kolbe, and N. Sfakianakis.
A mathematical insight in the epithelial-
17
DCC CSC ECM
u
n
if
or
m
E
C
M
0.3
0.6
0.9
0.013
0.027
0.04
0.3
0.7
1
h
et
er
o
ge
n
eo
u
s
E
C
M
0.3
0.6
0.9
0.23
0.47
0.7
0.03
0.07
0.1
Figure 9: Comparison of two invasion systems with uniform and non-uniform ECM, respectively. System
(17) is resolved with uniform initial ECM distribution (upper row,Experiment 7), and with non-uniform initial
distribution of the ECM (lower row, cf. Experiment 11). In both cases the ECM is degraded by the MMPs
and remodelled by the fibroblast cells. We observe a significant loss of symmetry in the invasion of the CSCs
with the higher concentrations following the structure of the ECM.
mesenchymal-like transition in cancer cells and
its effect in the invasion of the extracellular
matrix. Bull. Braz. Math. Soc., 47(1):397–412,
2016.
[21] W. Hundsdorfer and J.G. Verwer. Numer-
ical solution of time-dependent advection-
diffusion-reaction equations, volume 33.
Springer, 2003.
[22] Y. Imai, C.K.H. Leung, H.G. Friesen, and
R.P.C. Shiu. Epidermal growth factor recep-
tors and effect of epidermal growth factor on
growth of human breast cancer cells in long-
term tissue culture. Cancer Res., 42(11):4394–
4398, 1982.
[23] C. Jeulin, V. Seltzer, D. Bailbe´, K. Andreau,
and F. Marano. EGF mediates calcium-
activated chloride channel activation in the hu-
man bronchial epithelial cell line 16HBE14o-:
involvement of tyrosine kinase p60c-src. Am.
J. Physiol.-Lung C., 295(3):L489–L496, 2008.
[24] M.D. Johnston, P.K. Maini, S. Jonathan-
Chapman, C.M. Edwards, and W.F. Bodmer.
On the proportion of cancer stem cells in a tu-
mour. J. Theor. Biol., 266(4):708–711, 2010.
[25] R.N. Kaplan, R.D. Riba, S. Zacharoulis, A.H.
Bramley, L. Vincent, C. Costa, D.D. MacDon-
ald, D.K. Jin, K. Shido, S.A. Kerns, Z. Zhu,
D. Hicklin, Y. Wu, J.L. Port, N. Altorki,
E.R. Port, D. Ruggero, S.V. Shmelkov, K.K.
Jensen, S. Rafii, and D. Lyden. VEGFR1-
positive haematopoietic bone marrow progen-
itors initiate the pre-metastatic niche. Nature,
438(7069):820–827, 2005.
[26] Y. Katsumo, S. Lamouille, and R. Derynck.
TGF-β signaling and epithelial–mesenchymal
transition in cancer progression. Curr. Opin.
Oncol., 25(1):76–84, 2013.
[27] T. Kawamoto, J. Mendelsohn, A. Le, G.H.
Sato, C.S. Lazar, and G.N. Gill. Relation of
epidermal growth factor receptor concentra-
tion to growth of human epidermoid carcinoma
A431 cells. J. Biol. Chem., 259(12):7761–7766,
1984.
[28] E.F. Keller and L.A. Segel. Initiation of slime
mold aggregation viewed as an instability. J.
Theor. Biol., 26(3):399–415, 1970.
[29] C.A. Kennedy and M.H. Carpenter. Ad-
ditive Runge-Kutta schemes for convection-
diffusion-reaction equations. Appl. Numer.
Math., 1(44):139–181, 2003.
[30] D.H. Kim, K. Han, K. Gupta, K.W. Kwon,
K.Y. Suh, and A. Levchenko. Mechanosensi-
tivity of fibroblast cell shape and movement to
anisotropic substratum topography gradients.
Biomaterials, 30(29):5433–5444, 2009.
[31] Y. Kim and A. Friedmann. Interaction of tu-
mor with its micro-environment: A mathemat-
18
DCC CSC ECM
t
=
35
0.3
0.7
1
0.03
0.06
0.09
0.17
0.33
0.5
t
=
70
0.3
0.6
0.9
0.13
0.27
0.4
0.17
0.33
0.5
t
=
10
0
0.3
0.6
0.9
0.3
0.7
1
0.17
0.33
0.5
Figure 10: Invasion of the ECM (right) by the DCCs (left) and CSCs (center) including all the components
of the model: the ECM is assumed to be non-uniform and remodelled by the fibroblast cell, the EMT is EGF-
driven, and the proliferation is modelled by the positive-part logistic function. Note the wavy pattern due to
the CSCs migration of the ECM, Experiment 12.
ical model. B. Math. Biol., 72(5):1029–1068,
2010.
[32] P. Klein, D. Mattoon, M.A. Lemmon, and
J. Schlessinger. A structure-based model for
ligand binding and dimerization of EGF recep-
tors. P. Natl. Acad. Sci. USA, 101(4):929–934,
2004.
[33] N. Kolbe. Mathematical modelling and nu-
merical simulations of cancer invasion. Mas-
ter’s thesis, University of Mainz, supervised by
M. Luka´cˇova´-Medvid’ova´, and N. Sfakianakis,
2013.
[34] N. Kolbe, J. Kat’uchova´, N. Sfakianakis,
N. Hellmann, and M. Luka´cˇova´-Medvid’ova´.
A study on time discretization and adaptive
mesh refinement methods for the simulation of
cancer invasion : The urokinase model. Appl.
Math. Comput., 273:353–376, 2016.
[35] A. Kurganov and M. Luka´cˇova´-Medvid’ova´.
Numerical study of two-species chemotaxis
models. Discrete Cont. Dyn-B, 19(1):131–152,
2014.
[36] S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton,
A. Ayyanan, A.Y. Zhou, M. Brooks, F. Rein-
hard, C.C. Zhang, M. Shipitsin, L.L. Camp-
bell, K. Polyak, C. Brisken, J. Yang, and R.A.
Weinberg. The epithelial-mesenchymal tran-
sition generates cells with properties of stem
cells. Cell, 133(4):704–715, 2008.
[37] S.R. McDougall, A.R.A. Anderson, M.A.J.
Chaplain, and J.A. Sheratt. Mathematical
modelling of flow through vascular networks:
Implications for tumour-induced angiogenesis
and chemotherapy strategies. Bull. Math.
Biol., 64(4):673–702, 2002.
[38] F. Michor. Mathematical models of cancer
stem cells. J. Clin. Oncol., 26(17):2854–2861,
2008.
[39] A. Neagu, V. Mironov, I. Kosztin, B. Barz,
M. Neagu, R.A. Moreno-Rodriguez, R.R.
Markwald, and G. Forgacs. Computational
modelling of epithelial–mesenchymal transfor-
mations. Biosystems, 100(1):23–30, 2010.
[40] C.O. Nordling. A new theory on the cancer-
19
inducing mechanism. Br. J. Cancer, 7(1):68,
1953.
[41] F. O¨zcan, P. Klein, M.A. Lemmon, I. Lax, and
J. Schlessinger. On the nature of low-and high-
affinity EGF receptors on living cells. P. Natl.
Acad. Sci. USA, 103(15):5735–5740, 2006.
[42] L. Pareschi and G. Russo. Implicit-explicit
Runge-Kutta schemes and applications to hy-
perbolic systems with relaxation. J. Sci. Com-
put., 25(1-2):129–155, 2005.
[43] A.J. Perumpanani, J.A. Sherratt, J. Norbury,
and H.M. Byrne. Biological inferences from
a mathematical model for malignant invasion.
Invas. Metast., 16(4-5):209–221, 1996.
[44] L. Preziosi. Cancer modelling and simulation.
CRC Press, 2003.
[45] D.C. Radisky. Epithelial-mesenchymal transi-
tion. J. Cell Sci., 118(19):4325–4326, 2005.
[46] T. Reya, S.J. Morrison, M.F. Clarke, and I.L.
Weissman. Stem cells, cancer, and cancer stem
cells. Nature, 414(6859):105–111, 2001.
[47] K.C. Robbins, L. Summaria, D. Elwyn, and
G.H. Barlow. Further studies on the purifica-
tion and characterization of human plasmino-
gen and plasmin. J. Biol. Chem., 240(1):541–
550, 1965.
[48] K. Shien, S. Toyooka, H. Yamamoto,
J. Soh, M. Jida, K.L. Thu, S. Hashida,
Y. Makl, E. Ichlhara, H. Asano, K. Tsukuda,
N. Taglkawa, K. Klura, A.F. Gazdar, W.L.
Lam, and S. Miyoshi1. Acquired resistance
to EGFR inhibitors is associated with a mani-
festation of stem cell–like properties in cancer
cells. Cancer Res., 73(10):3051–3061, 2013.
[49] T. Stiehl and A. Marciniak-Czochra. Mathe-
matical modeling of leukemogenesis and cancer
stem cell dynamics. Math. Model Nat. Phe-
nom., 7(01):166–202, 2012.
[50] C. Stinner, C. Surulescu, and A. Uatay.
Global existence for a go-or-grow mul-
tiscale model for tumor invasion with
therapy. Preprint on webpage at http://nbn-
resolving.de/urn/resolver.pl?urn:nbn:de:hbz:386-
kluedo-42943, 2015.
[51] C.L. Stokes and D.A. Lauffenburger. Analysis
of the roles of microvessel endothelial cell ran-
dom motility and chemotaxis in angiogenesis.
J. Theor. Biol., 152(3):377–403, 1991.
[52] C.L. Stokes, D.A. Lauffenburger, and S.K.
Williams. Migration of individual microvessel
endothelial cells: stochastic model and param-
eter measurement. J. Cell Sci., 99(2):419–430,
1991.
[53] J.P. Thiery. Epithelial–mesenchymal transi-
tions in tumour progression. Nat. Rev. Cancer,
2(6):442–454, 2002.
[54] V. Vainstein, O.U. Kirnasovsky, Y. Kogan,
and Z. Agur. Strategies for cancer stem cell
elimination: Insights from mathematical mod-
elling. J. Theor. Biology, 298:32–41, 2012.
[55] B. Van Leer. Towards the ultimate conser-
vative difference scheme. IV. A new approach
to numerical convection. J. Comput. Phys.,
23(3):276–299, 1977.
[56] D.C. Voon, H. Wang, J.K.W. Koo, J.H. Chai,
Y.T. Hor, T.Z. Tan, Y.S. Chu, S. Mori, and
Y. Ito. EMT-induced stemness and tumori-
genicity are fueled by the EGFR/Ras pathway.
PLoS One, 8(8):e70427, 2013.
[57] X. Zhu, X. Zhou, M.T. Lewis, L. Xia, and
S. Wong. Cancer stem cell, niche and EGFR
decide tumor development and treatment re-
sponse: A bio-computational simulation study.
J. Theor. Biol., 269(1):138–149, 2011.
20
Appendix
Experiment description
Here we give technical details on the experiments that have been presented in this work. Our one-
dimensional simulations have been computed on the domain Ω = [0, 7.5] with the initial conditions (25),
and the experiments in two dimensions have been conducted on Ω = [−5, 5]2 with the initial data (26),
(27). Wherever not otherwise stated, we have employed the parameters from Table 1.
Experiment 1. One-dimensional, EGF driven EMT With parameters from Table 1 except for µ0 =
0.55, kD = 0.5, Γ = 7.5
−1. See also Figure 3 and 8. The convergence study (see Table 2) and the
sensitivity analysis, see Table 3, have been conducted on a smaller domain ΩS = [0, 3].
Experiment 2. One-dimensional, adjusted EMT The parameters have been adjusted, so that the inva-
siveness of the CSCs coincides with the Experiment 5: µ0 = 0.034, µ1/2 = 0.4, kD = 0.2, λ
D =
3, Γ = 7.5−1. See also Figure 6 (middle row).
Experiment 3. One-dimensional, adjusted EMT & low EGF Same as Experiment 2, with low EGF
concentration: µ0 = 0.034, µ1/2 = 0.4, kD = 0.2, λ
D = 3, Γ = 10−3. See also Figure 6 (lower
row).
Experiment 4. Adjusted EMT & low initial DCC concentration Same parameters as in Experiment
2. Advection and diffusion terms were neglected. The initial conditions cD0 = 10
−3, cS0 = 0, c
F
0 =
0, v0 = 1, m0 = 10
−6 have been employed. See also Figure 7 (left).
Experiment 5. One-dimensional, constant EMT rate Our EMT model from Section 2.2 has been ne-
glected, and the EMT transition coefficient in system (17) has been taken as a constant: µEMT = 0.017.
The invasiveness of the CSCs coincides with Experiment 2. See Figure 6 (upper row).
Experiment 6. Constant EMT rate & low initial DCC concentration Same parameters as in Experiment
5. Advection and diffusion terms were neglected. The initial conditions cD0 = 10
−3, cS0 = 0, c
F
0 =
0, v0 = 1, m0 = 10
−6, have been employed as in Experiment 4. See also Figure 7 (right).
Experiment 7. Two-dimensional, uniform ECM & fibroblast remodelling Parameters from Table 1. See
Figures 4 and 5 (lower row).
Experiment 8. Two-dimensional, uniform ECM & no remodelling Same as Experiment 7, without
matrix remodelling: µv = 0. See Figure 5 (upper row).
Experiment 9. Two-dimensional, uniform ECM & self remodelling Same as Experiment 7, with self-
remodelling, i.e. the term +µv c
F (1− cD − cS − cF − v)+ for the ECM in system (17) has been replaced
by +µv v (1− cD − cS − cF − v)+, hence the fibroblasts have been neglected. See Figure 5 (middle row).
Experiment 10. Two-dimensional, uniform ECM & fibroblast remodelling & smooth initial dataSame
as Experiment 7 with smooth initial data for the convergence study, see Table 2:
cD0 (x) = exp(−‖x‖22), cS0(x) = cF0 (x) = 0, v0(x) = 1− cD0 (x), m0(x) =
1
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cD0 (x), x = (x1, x2) ∈ Ω .
Experiment 11. Two-dimensional, non-uniform ECM Same as Experiment 7 with an ECM initial
concentration v0 different from (27). The non-uniform initial ECM v0 has been constructed by a random
distribution of fibroblast cell concentrations acting without other influences on the domain. We have
conducted the simulation on a 100 × 100 computational grid (lower resolution as opposed to the other
experiments). See Figure 9 lower row.
Experiment 12. Two-dimensional, non-uniform ECM Similar to Experiment 11, the non-uniform
initial ECM v0 has been constructed by a random distribution of fibroblast cell concentrations acting
21
on the domain. As a result the initial ECM concentration is different from the case in Experiment 11.
We have conducted the simulation using the standard grid resolution with 250 × 250 mesh cells. See also
Figure 10.
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